Loading...
Docoh

Wed. 10 Aug 2022, 5:23pm ET Benzinga Earnings

 

Evoke Pharma (NASDAQ:EVOK) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Evoke Pharma missed estimated earnings by 18.33%, reporting an EPS of $-0.71 versus an estimate of $-0.6.

Revenue was up $225 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.36 which was followed by a 21.74% drop in the share price the next day.

Here's a look at Evoke Pharma's past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.48 -0.96 -0.84 -0.96
EPS Actual -0.84 -0.72 -0.72 -0.84
Revenue Estimate 530K 510K 380K 150K
Revenue Actual 418K 360K 930K 236K

To track all earnings releases for Evoke Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.